Project Grant R00DE033421
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded The Ohio State University a Project Grant totaling $690,195 under the Oral Diseases and Disorders Research program (CFDA 93.121) on March 1, 2026, with completion scheduled for February 28, 2031. This research initiative investigates the neuroimmunological mechanisms regulating reparative dentinogenesis—the process of dentin repair following deep tooth injuries and inflammation. The...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded University of California, Los Angeles $180,943.00 under the Oral Diseases and Disorders Research program (CFDA 93.121) on June 13, 2025, for research addressing therapeutic targeting of apical periodontal T-cells in chronic oral inflammation. The research initiative, which extends through May 31, 2030, investigates the pathogenic mechanisms underlying apical periodontitis—a chronic...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded $540,629 to the University of Massachusetts Lowell on August 15, 2025, under the Oral Diseases and Disorders Research program (CFDA 93.121) to support research investigating human oral host-pathogen interactions and dysbiosis modulation. The project, scheduled for completion by August 14, 2027, focuses on developing and validating an immunocompetent three-dimensional (3D) in vitro model...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded the University of Illinois a $320,660 Project Grant on April 6, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to conduct basic research on the immunoregulatory function of dendritic cell subsets in periodontal disease. The 24-month research initiative, concluding April 5, 2028, will investigate how three dendritic cell subsets—myeloid dendritic cells...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded the Regents of the University of Michigan a $135,000 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) effective August 1, 2025, through July 31, 2027. This research initiative addresses the clinical need for non-toxic therapeutic approaches to treat apical periodontitis (AP) and pulpal necrosis in permanent teeth across all developmental stages. The project...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded Cleveland Clinic Lerner College of Medicine of Case Western Reserve University a $568,759 Project Grant effective May 1, 2026, through April 30, 2031, under the Oral Diseases and Disorders Research program (CFDA 93.121). This research initiative focuses on elucidating the pathogenic mechanisms underlying periodontitis through investigation of microbial synergy and immune subversion. The project...
- Federal Grant Award Summary Award Details: The National Institute of Dental and Craniofacial Research (NIDCR) awarded Augusta University Research Institute, Inc. a Project Grant totaling $645,009 under the Oral Diseases and Disorders Research program (CFDA 93.121). The award period runs from June 15, 2025, through June 14, 2027. Research Scope: This grant funds a research project investigating the molecular mechanisms of alveolar bone loss in periodontitis through examination of...
- Grant Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $100,676 Project Grant to the University of Massachusetts Lowell under the Oral Diseases and Disorders Research program (CFDA 93.121) on September 30, 2026, with completion targeted for April 14, 2027. This research project develops a three-dimensional (3D) in vitro human periodontal sulcus tissue model designed to advance understanding of oral dysbiosis—the disruption of microbial balance in gum tissue....
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research awarded a Project Grant of $239,405 to Massachusetts General Hospital (The General Hospital Corporation) for the period July 1, 2025 through June 30, 2027, under the Oral Diseases and Disorders Research program (CFDA 93.121). The research focuses on elucidating the neural circuit mechanisms underlying peripheral nerve stimulation (PNS) as a treatment for trigeminal neuropathic pain (TNP), a condition...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research awarded $870,334 under the Oral Diseases and Disorders Research program (CFDA 93.121) to The Research Foundation for the State University of New York for a project spanning August 1, 2025, through July 31, 2027. The project focuses on developing an early tooth organoid utilizing human induced pluripotent stem cells (iPSCs), addressing a critical gap in understanding early tooth development. The research...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $249,000 Project Grant to Boston University Medical Campus, effective May 1, 2026 through April 30, 2031, under the Oral Diseases and Disorders Research program (CFDA 93.121). This five-year research initiative will investigate the mechanisms underlying pulpitis—a painful inflammatory disease of the dental pulp—by examining the complex interactions between neutrophils and sensory neurons. The research will generate fundamental knowledge through multiple scientific methodologies including animal models of pulpitis, tissue-clearing and whole-mount imaging, single-nuclei RNA sequencing, in-situ hybridization, chemogenetic approaches, and pain behavior assays to identify how neutrophil-driven nerve injury contributes to pain outcomes and how nociceptive neurons modulate innate immune responses. The project will deliver three primary research products through a comprehensive investigation of neuro-immune interactions within the pulp-periodontium complex. Aim 1 will produce anatomical and transcriptional data characterizing neutrophil-driven nerve injury mechanisms and pain responses during pulpitis. Aim 2 will generate flow cytometry and enzyme-linked immunosorbent assay (ELISA) results demonstrating the impact of nociceptive neuron activation on neutrophil recruitment and immune function. Aim 3 will identify distinct inflammatory signatures and mechanisms specific to the pulp-periodontium interface. These research outputs are designed to inform the development of conservative treatment strategies and novel pain management approaches that would reduce reliance on invasive procedures such as root canal therapy and tooth extractions.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $249.0k | 6/3/26 |